|
|
|
| Clinical effect of Jiawei Buzhong Yiqi Decoction in the auxiliary treatment of chronic obstructive pulmonary disease with respiratory failure |
| AN Huiming MIAO Dandan LYU Beibei QI Shubin |
| Intensive Care Unit, Xianxian Hospital of Traditional Chinese Medicine of Cangzhou City in Hebei Province, Hebei Province, Xianxian 062250, China |
|
|
|
Abstract Objective To analyze clinical effect of Jiawei Buzhong Yiqi Decoction in the auxiliary treatment of chronic obstructive pulmonary disease with respiratory failure. Methods Ninety-two patients of chronic obstructive pulmonary disease with respiratory failure treated in Xianxian Hospital of Traditional Chinese Medicine of Cangzhou City in Hebei Province from February 2018 to February 2019 were selected as study samples. They were divided into routine group and experimental group by random number table method, with 46 cases in each group. Routine group was treated with basic Western medicine, experimental group was treated with basic Western medicine and Jiawei Buzhong Yiqi Decoction for 4 weeks. Traditional Chinese medicine syndrome score, heart rate, respiration rate, oxygen partial pressure, carbon dioxide partial pressure, vital capacity, forced expiratory volume in the first second and peak expiratory velocity, St.George′s respiratory disease questionnaire score between two groups were compared before and after treatment. The therapeutic effect of two groups was observed. Results After treatment, the scores of traditional Chinese medicine syndromes in two groups were lower than those before treatment (P < 0.05), and the scores in experimental group were lower than those in routine group (P < 0.05). After treatment, the heart rate and respiration of two groups were slower than those before treatment, the level of carbon dioxide partial pressure was lower than that before treatment, the level of oxygen partial pressure was higher than that before treatment (P < 0.05), and the improvement of experimental group was better than that of routine group (P < 0.05). After treatment, the vital capacity, forced expiratory volume in the first second and peak expiratory velocity in two groups were higher than those before treatment (P < 0.05), and experimental group was higher than that in routine group (P < 0.05). Total effective rate of experimental group was higher than that of routine group (P < 0.05). After treatment, the scores of disease performance, disease influence and activity disorder in two groups were lower than those before treatment (P < 0.05), and the scores in experimental group were lower than those in routine group (P < 0.05). Conclusion The auxiliary treatment of Jiawei Buzhong Yiqi Decoction can improve the curative effect, clinical performance, lung function and life quality of patients with chronic obstructive pulmonary disease and respiratory failure. It has certain clinical application value.
|
|
|
|
|
|
[1] 潘兴，王黎青，王慧铃.患者教育对慢性阻塞性肺疾患者者干粉吸入剂使用正确率及依从性的影响[J].临床肺科杂志，2019，24（11）：1952-1956.
[2] 王青.慢性阻塞性肺疾病与哮喘-慢性阻塞性肺疾病重叠的临床特征及预后分析[J].山西医药杂志，2019，48（19）：2398-2400.
[3] 胡祥坤，潘春香，孙如坤，等.布地奈德福莫特罗吸入治疗对慢性阻塞性肺疾病合并肺癌患者呼吸动力学的影响[J].临床心身疾病杂志，2019，25（6）：24-27.
[4] 李治军，刘明，易小玲，等.西药联合芪黄益肺合剂治疗慢性阻塞性肺疾病急性加重期肺肾气虚证临床观察[J].中国民族民间医药，2019，28（20）：99-101.
[5] 葛均波，徐永健.内科学[M].8版.北京：人民卫生出版社，2013：227-255，741-742.
[6] 周仲英.中医内科学[M].北京：中国中医药出版社，2010：108-109.
[7] 李建生，余学庆.慢性阻塞性肺疾病中医分期分级防治策略[J].中医杂志，2019，60（22）：1895-1899.
[8] 庄丽，梁健，张宏，等.金水宝胶囊联合羧甲司坦治疗慢性阻塞性肺疾病稳定期的临床研究[J].现代药物与临床，2019，34（10）：2975-2979.
[9] 李彩平，李海荣.信必可都保联合呼吸训练对慢性阻塞性肺疾病稳定期的患者肺功能及血气分析的疗效探讨[J].护理学，2019，8（2）：36-40.
[10] 冷婷，任惠，周雨婷.老年慢性阻塞性肺疾病合并肺栓塞患者的临床特征及其危险因素分析[J].中国医学前沿杂志：电子版，2019，11（9）：73-76.
[11] 杨亚萍，邢江，冀美佳，等.慢性阻塞性肺疾患者者自主神经功能的相关影响因素分析[J].现代中西医结合杂志，2019，28（29）：3211-3214，3263.
[12] 柴书坤，王小琳，史金英，等.经鼻高流量吸氧治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭的临床研究[J].河北医药，2019，41（20）：3110-3113，3117.
[13] 李战炜，唐伟.培土生金方联合BiPAP呼吸机对慢性阻塞性肺疾病加重期合并Ⅱ型呼吸衰竭痰细胞分类、血ECP变化的影响[J].世界中西医结合杂志，2019，14（10）：1415-1418.
[14] 陈会正.参芪补肺汤对慢性阻塞性肺疾病稳定期肺气虚证患者的临床疗效影响分析[J].中国保健营养，2019， 29（29）：289-290.
[15] 刘继民.中药加味四君子汤颗粒剂对提高慢性阻塞性肺疾患者者运动耐力的康复效果观察[J].中国保健营养，2019，29（32）：35-36.
[16] 牛逸群，王珏云，李得民，等.宣白承气汤联合西医常规治疗慢性阻塞性肺疾病急性加重期系统评价[J].中国中医药信息杂志，2019，26（10）：85-90.
[17] 范娟娟，严红美，杨建萍.养阴清肺汤加味联合西药治疗慢性阻塞性肺疾病稳定期的临床疗效观察[J].中国现代医生，2019，57（28）：134-137.
[18] 郭光辉，郑岚，杨宏志，等.化痰降气活血汤联合常规西药治疗哮喘-慢性阻塞性肺疾病重叠的临床效果[J].中国医药导报，2019，16（26）：137-140，144.
[19] 李利沙.益气补肺汤联合布地奈德对慢性阻塞性肺疾患者者肺功能和血清炎症因子水平的影响[J].河南医学研究，2019，28（18）：3396-3397.
[20] 彭磊，夏卫明，何健忠，等.温阳化痰汤对慢性阻塞性肺疾病急性加重合并肺源性心脏病（痰湿阳虚证）的临床研究[J].中国中医急症，2019，28（8）：1423-1426.
[21] 焦小强，周继红，李晶，等.益气活血化痰汤治疗慢性阻塞性肺疾病伴呼吸衰竭40例[J].河南中医，2019，39（6）：890-893. |
|
|
|
